Annotated Medicine and Device Lists

Lisinopril + amlodipine

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Therapeutic alternatives: - 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) (for lisinopril) - 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine)

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Therapeutic alternatives: - 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) (for lisinopril) - 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine)

This medicine is present in:

List Section Observation
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Therapeutic alternatives: - 4th level ATC chemical subgroup (C09AA ACE inhibitors, plain) (for lisinopril) - 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine)

Information Resources: Lisinopril + amlodipine

No information available